ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 18 USD 2.33%
Market Cap: 3B USD
Have any thoughts about
ACADIA Pharmaceuticals Inc?
Write Note

ACADIA Pharmaceuticals Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ACADIA Pharmaceuticals Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Retained Earnings
-$2.3B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-17%
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$25.5B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-18%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$30.8B
CAGR 3-Years
22%
CAGR 5-Years
36%
CAGR 10-Years
71%

See Also

What is ACADIA Pharmaceuticals Inc's Retained Earnings?
Retained Earnings
-2.3B USD

Based on the financial report for Sep 30, 2024, ACADIA Pharmaceuticals Inc's Retained Earnings amounts to -2.3B USD.

What is ACADIA Pharmaceuticals Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-17%

Over the last year, the Retained Earnings growth was 5%. The average annual Retained Earnings growth rates for ACADIA Pharmaceuticals Inc have been -4% over the past three years , -7% over the past five years , and -17% over the past ten years .

Back to Top